Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Mol Cancer Res. 2019 Feb 7;17(5):1036–1048. doi: 10.1158/1541-7786.MCR-18-1026

Table 2.

Mutational Analysis of the CUTC cell lines and PDX model.

BRAF HRAS TERT TP53
CUTC5 c.T1799TA
[p.V600E]
WT WT c.C405G
[p.C135W]
CUTC48 WT WT c.−124C>T WT
CUTC60 c.T1799A
[p.V600E]
WT c.−124C>T c.A578G
[p.H193R]
CUTC60-PDX c.T1799TA
[p.V600E]
WT c.−124C>T c.A578G
[p.H193R]
CUTC61 WT c.A182G
[p.Q61R]
c.−124C>T Splicing
c.375+1G>A